DOCS 240920 37.50P (DOCS240920P37500) Stock Options, News & Quotes

1.35
-0.20-12.90%

15min DelayClose Aug 23 16:00 ET

1.50High1.35Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

pachi

May 19 22:48

$Doximity (DOCS.US)$
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.

Moomoo AI

Mar 26 06:01

Doximity's high P/E ratio is backed by its promising earnings outlook. Shareholders, confident in future earnings, are holding onto their shares. The company's robust earnings growth and positive future outlook bolster its share price.

Investors Still Waiting For A Pull Back In Doximity, Inc. (NYSE:DOCS)

Meltyy

Nov 27, 2023 01:46

Telehealth Stocks DD

The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
$Teladoc Health (TDOC.US)$
A...

Moomoo AI

Nov 10, 2023 07:49

Analysts from William Blair and Raymond James rate DOCS shares as 'Outperform', remaining optimistic about the company's future. They find the solid results and improved guidance range to be a positive step.

Doximity Stock Rallies. Guidance Boost 'Just What the Doctor Ordered.' -- Barrons.com

Moomoo AI

Oct 29, 2023 10:02

Doximity's underpriced shares and forecasted profitability increase its appeal among big growth investors. Its bright future prospects are not entirely factored into its current share price. However, it's recommended to examine the company's finance before investment.

Is It Too Late To Consider Buying Doximity, Inc. (NYSE:DOCS)?